Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pancreatic Neoplasms 3Breast Neoplasms 3Pancreatic Adenocarcinoma 2Stomatitis 1Radiation Fibrosis Syndrome 1Peripheral Nervous System Diseases 1Neuroma, Acoustic 1Neoplasms 1Inflammation 1Hypertension 1Glioblastoma 1Fibrosis 1Fallopian Tube Neoplasms 1Coronavirus Infections 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Camurati-Engelmann Syndrome 1COVID-19 1Brain Neoplasms 1

Interventions

Bevacizumab 3Everolimus 2tozuleristide 1neratinib 1icotinib 1brigatinib 1Sirolimus 1Mn-PyC3A 1Losartan 1Lapatinib 1Fluoresceins 1Fluorescein 1Endostatins 1Axitinib 1Aspirin 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuroma, Acoustic × Losartan × Clear all
NCT01199978 2025-10-01

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Massachusetts General Hospital

Phase 2 Active not recruiting
30 enrolled
CNS

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡